AbbVie Expands Immunology Portfolio in Canada as Health Canada approves SKYRIZI® for the Treatment of Adults with Active Psoriatic Arthritis - InvestingNews.com

AbbVie Expands Immunology Portfolio in Canada as Health Canada approves SKYRIZI for the Treatment of Adults with Active Psoriatic ArthritisInvestingNews.

Read Full Story: https://investingnews.com/abbvie-expands-immunology-portfolio-in-canada-as-health-canada-approves-skyrizi-r-for-the-treatment-of-adults-with-active-psoriatic-arthritis/

Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.


Source: NewsService